ArticleNews reportPHN-05812026-11-03 16:28 CT

What is a ‘Wolverine shot’? The biohacking booster athletes love

Source · New York Post

TLDR

The New York Post reports growing interest in the “Wolverine shot,” a combination of BPC-157 and TB-500 promoted for fitness recovery despite limited scientific evidence. The article says both compounds lack FDA approval and reports that a human trial of BPC-157 after shoulder surgery is planned for summer 2027.

01—Key points

01The article describes recovery claims as supported by animal and laboratory research rather than human testing.
02Quoted experts distinguish these experimental compounds from approved peptide medicines and raise concerns about contamination and unknown long-term effects.
03The planned randomized, double-blind, placebo-controlled trial will assess postoperative healing and side effects.

Why it matters Editorial

The report highlights a gap between enthusiasm for experimental recovery peptides and evidence establishing their safety and effectiveness in humans.

Read the original at New York Post↗

Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.